Download video

Dr. Chi on Abiraterone Versus Enzalutamide for Metastatic Castration-Resistant Prostate Cancer

5.1K views

OncLive

7 years ago

Dr. Chi on Abiraterone Versus Enzalutamide for Metastatic Castration-Resistant Prostate Cancer

Dr. Chi on Abiraterone Versus Enzalutamide for Metastatic Castration-Resistant Prostate Cancer

Dr. Chi on Abiraterone Versus Enzalutamide for Metastatic Castration-Resistant Prostate Cancer
1:34
Dr. Chi on Abiraterone Versus Enzalutamide for Metastatic Castration-Resistant Prostate Cancer
by OncLive
Dr. Crawford on Abiraterone Versus Enzalutamide in Prostate Cancer
0:59
Dr. Crawford on Abiraterone Versus Enzalutamide in Prostate Cancer
by OncLive
CARD: Cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer
4:34
CARD: Cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer
by ecancer
Abiraterone vs docetaxel for metastatic castrate resistant prostate cancer
1:53
Abiraterone vs docetaxel for metastatic castrate resistant prostate cancer
by ecancer
Head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic CRPC
2:13
Head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic CRPC
by VJOncology
Treatment sequencing in mCRPC: cabazitaxel vs. abiraterone or enzalutamide
1:52
Treatment sequencing in mCRPC: cabazitaxel vs. abiraterone or enzalutamide
by VJOncology
Dr. Dreicer on Abiraterone and Enzalutamide in Prostate Cancer
1:14
Dr. Dreicer on Abiraterone and Enzalutamide in Prostate Cancer
by OncLive
Dr. Charles Ryan Discusses Abiraterone and Enzalutamide for mCRPC
2:09
Dr. Charles Ryan Discusses Abiraterone and Enzalutamide for mCRPC
by Targeted Oncology
Dr. Pal on Sequencing Abiraterone and Enzalutamide in mCRPC
1:12
Dr. Pal on Sequencing Abiraterone and Enzalutamide in mCRPC
by Targeted Oncology
Dr. Sweeney on Chemotherapy Versus Abiraterone for mCRPC
1:55
Dr. Sweeney on Chemotherapy Versus Abiraterone for mCRPC
by OncLive
Oral Hormonal Agents for Metastatc Castration-Resistant Prostate Cancer
5:37
Oral Hormonal Agents for Metastatc Castration-Resistant Prostate Cancer
by OncLive
Enzalutamide in the Context of Nonmetastatic CRPC
3:06
Enzalutamide in the Context of Nonmetastatic CRPC
by OncLive
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
2:59
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
by ASCOcancer
Metastatic castration-resistant prostate cancer – New learnings and perspectives
5:46
Metastatic castration-resistant prostate cancer – New learnings and perspectives
by European Association of Urology
The use of abiraterone and enzalutamide against CRPC
8:12
The use of abiraterone and enzalutamide against CRPC
by ecancer
Updates from the CHEIRON study: docetaxel plus enzalutamide for mCRPC
3:44
Updates from the CHEIRON study: docetaxel plus enzalutamide for mCRPC
by VJOncology
Dr. Nicholas Vogelzang Discusses Sequencing Abiraterone and Enzalutamide
1:53
Dr. Nicholas Vogelzang Discusses Sequencing Abiraterone and Enzalutamide
by OncLive
Dr. Hahn on Patients With Prostate Cancer Whom Neither Docetaxel or Abiraterone is an Option
0:45
Dr. Hahn on Patients With Prostate Cancer Whom Neither Docetaxel or Abiraterone is an Option
by OncLive
Dr. Chi on Androgen Deprivation Therapy for High-Risk Metastatic Hormone-Naive Prostate Cancer
2:06
Dr. Chi on Androgen Deprivation Therapy for High-Risk Metastatic Hormone-Naive Prostate Cancer
by OncLive
Current standards for first-line metastatic hormone-sensitive prostate cancer
2:10
Current standards for first-line metastatic hormone-sensitive prostate cancer
by VJOncology